Epstein-Barr Virus (EBV) Acute Infection Antibodies Profile

CPT: 86663; 86664; 86665(x2)
Print Share


  • EBV Acute Infection Antibodies

Test Includes

EBV-EA, IgG; EBV-VCA, IgG; EBV-VCA, IgM; Epstein-Barr nuclear antigen antibodies (EBNA); interpretation

Expected Turnaround Time

1 - 2 days

Related Documents

Specimen Requirements




2 mL

Minimum Volume

1 mL


Red-top tube or gel-barrier tube

Storage Instructions

Room temperature. Specimen is stable for two days at room temperature or refrigerated. For storage longer than two days, freeze the specimen.

Causes for Rejection

Hemolysis; lipemia; grossly icteric; visible particulate matter; gross bacterial contamination

Test Details


Differentiation of acute from chronic or reactivated infections with Epstein-Barr virus


The results from this panel are not by themselves diagnostic and should be considered in association with other clinical data and patient symptoms.

This test is intended for qualitative determination only. The numeric value of the final result above the cutoff is not indicative of the amount of antibodies present.


Chemiluminescent immunoassay (CLIA)

Reference Interval

See individual tests.

Additional Information

Epstein-Barr (EB) virus is a herpes group virus that is ubiquitous. It is the cause of classic infectious mononucleosis and is causally implicated in the pathogenesis of Burkitt lymphoma, some nasopharyngeal carcinomas, and rare hereditary lymphoproliferative disorders. The serologic response to EB virus includes antibody to early antigen, IgM and IgG antibodies to viral capsid antigen (VCA), and antibodies to Epstein-Barr nuclear antigen (EBNA).

Although most cases of infectious mononucleosis can be diagnosed on the basis of clinical findings, blood count and morphology, and a positive test for heterophile antibody, as many as 20% may be heterophile-negative, at least at presentation (Heterophile may become positive when repeated in a few days). In some of these cases, a test for Epstein-Barr virus antibodies may be useful.

The most controversial use of EBV serology is in chronic fatigue syndrome, a complaint predominantly (but not exclusively) of young to middle-aged women, characterized by long persistent debilitating fatigue and a panoply of usually mild somatic complaints. The high levels of EBV antibodies in the general population, their long persistence, and the poor correlation of antibody titers with symptoms combine to make EBV serology useless in diagnosing, following, or ruling out chronic fatigue syndrome. See table.

EBV Interpretation Table






Key — Antibody present: + Antibody absent: −

EBV seronegative

Early phase


Acute primary infection




Convalescence/past infection




Reactivated infection






Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC
216655 EBV Acute Infection Antibodies 096739 EBV Ab VCA, IgM U/mL 5159-9
216655 EBV Acute Infection Antibodies 096252 EBV Early Antigen Ab, IgG U/mL 24007-7
216655 EBV Acute Infection Antibodies 096235 EBV Ab VCA, IgG U/mL 5157-3
216655 EBV Acute Infection Antibodies 010276 EBV Nuclear Antigen Ab, IgG U/mL 30083-0
216655 EBV Acute Infection Antibodies 169992 Interpretation: 8251-1

For Providers

Please login to order a test.


© 2019  Laboratory Corporation of America® Holdings and Lexi-Comp Inc. All Rights Reserved.

CPT Statement/Profile Statement

The LOINC® codes are copyright © 1994-2018, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. Permission is granted in perpetuity, without payment of license fees or royalties, to use, copy, or distribute the LOINC® codes for any commercial or non-commercial purpose, subject to the terms under the license agreement found at https://loinc.org/license/. Additional information regarding LOINC® codes can be found at LOINC.org, including the LOINC Manual, which can be downloaded at LOINC.org/downloads/files/LOINCManual.pdf